Summary:
We are currently recruiting participants for a clinical research study to compare the effectiveness of an investigational medication compared to an FDA approved medication in patients with type 2 diabetes inadequately controlled with metformin alone.
Qualified Participants Must:
• Be 18 years of age or older
•
Have a clinical diagnosis of type 2 diabetes mellitus (T2DM)
•
Have diagnosis of diabetes for at least 1 year
•
Be on a stable dose of at least 1,500 mg per day of metformin (or maximum tolerated dose)
•
Have an HbA1c between 7.0% and 10.0%, inclusive
Qualified Participants May Receive:
- Reimbursement for time and travel
- Study-related care and study medicine at no cost (no health insurance required)